Understanding how cells specialize during early embryonic development is essential for progress in regenerative medicine and developmental biology. Pluripotent stem cells (PSCs) are crucial in this research, as they can become various cell types and are central to early development. However, studies involving human and primate PSCs have faced ethical and technical challenges.

Naive-type PSCs, which are at an earlier developmental stage than conventional or ‘primed’ PSCs, have shown greater potential for differentiation. Human naive PSCs can develop into both embryonic and extra-embryonic tissues, such as the placenta and yolk sac, while mouse naive PSCs cannot. This difference raises questions about whether this capability is unique to humans or shared with other primates.

A study led by Hideki Masaki at the Institute of Science Tokyo, published in Cell Stem Cell, addressed this question by establishing naive-type induced pluripotent stem cells from chimpanzee somatic cells. The team also became the first to generate chimpanzee blastoids—early embryo models—using these cells.

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

A key finding was that inhibiting polycomb repressive complex 2 (PRC2), a protein involved in gene regulation, is essential for the growth of chimpanzee naive PSCs. Without PRC2 inhibition, the cells could not proliferate after reprogramming. The chimpanzee naive PSCs demonstrated gene expression and developmental potential similar to human naive PSCs, including the ability to differentiate into trophectoderm and hypoblast, tissues vital for embryo implantation and development. This enabled the creation of tri-lineage blastoids containing all three early embryonic cell types.

The researchers also developed a feeder-free culture system for naive PSCs by using PRC2 inhibitors, eliminating the need for animal-derived feeder cells. According to Masaki, “Our success in establishing a culturing technique without feeder cells may pave the way to applications in regenerative medicine.”